Efficacy and Safety of Leuprolide Acetate 3-Month Depot 11.25 Milligrams or 30 Milligrams for the Treatment of Central Precocious Puberty

医学 车辆段 骨龄 不利影响 内科学 内分泌学 亮丙瑞林 睾酮(贴片) 性早熟 骨成熟 兴奋剂 促性腺激素释放激素 促黄体激素 激素 受体 考古 历史
作者
Peter A. Lee,Karen Oerter Klein,Nelly Mauras,E. Kirk Neely,C Bloch,Lois Larsen,Cynthia Mattia-Goldberg,Kristof Chwalisż
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [Oxford University Press]
卷期号:97 (5): 1572-1580 被引量:51
标识
DOI:10.1210/jc.2011-2704
摘要

GnRH agonist (GnRHa) monthly injections are frequently used in the treatment of central precocious puberty (CPP). The 3-month leuprolide depot 11.25- and 30-mg formulations are newly approved treatment options.The aim of the study was to investigate the safety and efficacy of leuprolide acetate 3-month depot formulations for the treatment of CPP in children.This was a phase III, randomized, open-label, dose-ranging 6-month study.Twenty-two U.S. medical centers (including Puerto Rico) participated.Children diagnosed with CPP (n = 84), who were either treatment naive or previously treated with GnRHa, were recruited. Chronological age at onset of pubertal signs was less than 8 yr in girls and less than 9 yr in boys, and bone age was advanced over chronological age at least 1 yr.Leuprolide acetate depot (11.25 or 30 mg) was administered im every 3 months.Biochemical [peak-stimulated LH, estradiol (girls), and testosterone (boys)] and anthropometric (growth rate, bone age acceleration, pubertal progression) parameters and safety were assessed.Peak-stimulated LH was suppressed in the 11.25- and 30-mg dose groups in 78.4 and 95.2%, respectively, of children from months 2 through 6. There were nine treatment failures (peak-stimulated LH >4 IU/liter) in the 11.25-mg group and two in the 30-mg group. Basal sex steroid suppression, growth rates, pubertal progression, bone age advancement, and adverse events were similar with either dose.Treatment with leuprolide acetate 3-month depot formulations (11.25 and 30 mg) effectively suppressed the GnRH axis, was well tolerated, and may positively impact patient convenience and compliance.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Wang完成签到,获得积分10
刚刚
qian发布了新的文献求助10
刚刚
赘婿的应助被氨气采纳,获得10
刚刚
刚刚
唐正皓发布了新的文献求助10
刚刚
勤恳的老姆完成签到,获得积分10
刚刚
蚂蚁完成签到,获得积分10
刚刚
1秒前
大模型的应助被江sir采纳,获得50
1秒前
1秒前
Zhoushuang完成签到,获得积分10
2秒前
2秒前
2秒前
马宇飞发布了新的文献求助10
2秒前
BEMJ发布了新的文献求助10
3秒前
Wang发布了新的文献求助10
3秒前
dwass完成签到,获得积分10
3秒前
3秒前
3秒前
褚褚完成签到,获得积分10
3秒前
可爱的函函的应助被tang采纳,获得30
4秒前
沉静白凡完成签到,获得积分10
4秒前
dj完成签到,获得积分10
4秒前
小马甲的应助被Lee采纳,获得10
4秒前
zdx完成签到,获得积分10
5秒前
Jyouang发布了新的文献求助10
5秒前
一百完成签到,获得积分10
5秒前
qq完成签到,获得积分10
6秒前
莽兽鳞上最黑的皮完成签到,获得积分10
6秒前
6秒前
Gabriel1116发布了新的文献求助10
6秒前
科研通AI65的应助被xh采纳,获得10
7秒前
秋风的应助被yj采纳,获得10
7秒前
7秒前
WLM发布了新的文献求助10
7秒前
小魏小魏发布了新的文献求助10
7秒前
7秒前
7秒前
Sandclub发布了新的文献求助10
7秒前
ding的应助被Code_king采纳,获得50
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175943
求助须知:如何正确求助?哪些是违规求助? 9567501
关于积分的说明 21793186
捐赠科研通 7770490
什么是DOI,文献DOI怎么找? 3431935
关于科研通互助平台的介绍 2556294
邀请新用户注册赠送积分活动 2477485